A leadership transition in the US Food & Drug Administration Office of Immunology & Inflammation will test the durability of the new drug review structure implemented by the agency’s Center for Drug Evaluation & Research at the start of the current decade.
Former rheumatology division Director Nikolay Nikolov is now acting director of OII, succeeding Julie Beitz, who retired after 30 years...